These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8818243)
1. Theoretical structure-activity studies of adenosine A1 ligands: requirements for receptor affinity. Dooley MJ; Kono M; Suzuki F Bioorg Med Chem; 1996 Jun; 4(6):923-34. PubMed ID: 8818243 [TBL] [Abstract][Full Text] [Related]
2. Relative binding orientations of adenosine A1 receptor ligands--a test case for Distributed Multipole Analysis in medicinal chemistry. van der Wenden EM; Price SL; Apaya RP; IJzerman AP; Soudijn W J Comput Aided Mol Des; 1995 Feb; 9(1):44-54. PubMed ID: 7751869 [TBL] [Abstract][Full Text] [Related]
3. Ribose modified nucleosides and nucleotides as ligands for purine receptors. Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046 [TBL] [Abstract][Full Text] [Related]
4. KW-3902, a selective high affinity antagonist for adenosine A1 receptors. Nonaka H; Ichimura M; Takeda M; Kanda T; Shimada J; Suzuki F; Kase H Br J Pharmacol; 1996 Apr; 117(8):1645-52. PubMed ID: 8732272 [TBL] [Abstract][Full Text] [Related]
5. Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. Jacobson KA; Gao ZG; Chen A; Barak D; Kim SA; Lee K; Link A; Rompaey PV; van Calenbergh S; Liang BT J Med Chem; 2001 Nov; 44(24):4125-36. PubMed ID: 11708915 [TBL] [Abstract][Full Text] [Related]
6. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor. Cohen FR; Lazareno S; Birdsall NJ Br J Pharmacol; 1996 Apr; 117(7):1521-9. PubMed ID: 8730749 [TBL] [Abstract][Full Text] [Related]
7. Binding thermodynamics of adenosine A2a receptor ligands. Borea PA; Dalpiaz A; Varani K; Guerra L; Gilli G Biochem Pharmacol; 1995 Feb; 49(4):461-9. PubMed ID: 7532939 [TBL] [Abstract][Full Text] [Related]
8. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists. van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors. Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575 [TBL] [Abstract][Full Text] [Related]
10. Adenosine receptor ligands: where are we, and where are we going? Tuccinardi T; Martinelli A Curr Top Med Chem; 2010; 10(10):941. PubMed ID: 20681944 [No Abstract] [Full Text] [Related]
11. Binding thermodynamics at A1 and A2A adenosine receptors. Borea PA; Dalpiaz A; Varani K; Gessi S; Gilli G Life Sci; 1996; 59(17):1373-88. PubMed ID: 8890916 [TBL] [Abstract][Full Text] [Related]
12. Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature. Sousa JB; Fresco P; Diniz C; Goncalves J Recent Pat Anticancer Drug Discov; 2018; 13(1):40-69. PubMed ID: 29119938 [TBL] [Abstract][Full Text] [Related]
13. Medicinal chemistry of adenosine A1 receptor ligands. Soudijn W; van Wijngaarden I; IJzerman AP Curr Top Med Chem; 2003; 3(4):355-67. PubMed ID: 12570755 [TBL] [Abstract][Full Text] [Related]
14. A1 adenosine receptors and their ligands: overview and recent developments. Müller CE Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971 [TBL] [Abstract][Full Text] [Related]
15. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex. Kirk IP; Richardson PJ Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753 [TBL] [Abstract][Full Text] [Related]
16. Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells. Hettinger-Smith BD; Leid M; Murray TF J Neurochem; 1996 Nov; 67(5):1921-30. PubMed ID: 8863496 [TBL] [Abstract][Full Text] [Related]
17. Intrinsic activity at adenosine A1 receptors: partial and inverse agonism. de Ligt RA; IJzerman AP Curr Pharm Des; 2002; 8(26):2333-44. PubMed ID: 12369948 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor. Kourounakis A; Visser C; de Groote M; IJzerman AP Biochem Pharmacol; 2001 Jan; 61(2):137-44. PubMed ID: 11163328 [TBL] [Abstract][Full Text] [Related]
19. Molecular modeling the human A1 adenosine receptor and study of the mechanisms of its selective ligand binding. Ivanov AA; Baskin II; Palyulin VA; Zefirov NS Dokl Biochem Biophys; 2002; 386():271-4. PubMed ID: 12469507 [No Abstract] [Full Text] [Related]
20. Expeditious synthesis and biological evaluation of new C-6 1,2,3-triazole adenosine derivatives A1 receptor antagonists or agonists. Mathew SC; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Rodriguez J; Parrain JL; Guieu R Org Biomol Chem; 2010 Sep; 8(17):3874-81. PubMed ID: 20617271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]